about
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library.Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesAWZ1066S, a highly specific anti- drug candidate for a short-course treatment of filariasisBoron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisPreclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasisDevelopment of a High-Throughput Cytometric Screen to Identify Anti- Wolbachia Compounds: The Power of Public-Private Partnership
P50
Q30377066-F207611B-362E-4AD8-A465-681AF3304DE3Q35297570-FE173B7A-2718-4899-92D6-4A7109D0A44AQ36708214-BBD3DBA4-A56A-4090-9CFC-BC3686FE844AQ41678406-62344770-15C5-4917-A106-B48FDB13FAB9Q44288385-601BFAC1-7ACD-4537-9C91-2656A3270520Q48215342-81F97059-0A1F-4064-81FC-1F070E958FE4Q50120566-F58381E9-3E9D-484A-818D-0301BEE60092Q60922213-957929AC-A496-4003-B1DF-2065A47A1E86Q61450807-DA063C7C-454D-4917-AB23-A2DE21FB40EDQ64268314-FB202EAF-0891-4E4F-93DB-62A317F43B72Q92340277-03D79EEC-092A-4BC3-BCD2-FF9FC6B4F062Q92927873-A6E851BB-6784-4C2C-BB7F-36ABAA49BBB4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rachel H Clare
@ast
Rachel H Clare
@en
Rachel H Clare
@es
Rachel H Clare
@nl
type
label
Rachel H Clare
@ast
Rachel H Clare
@en
Rachel H Clare
@es
Rachel H Clare
@nl
prefLabel
Rachel H Clare
@ast
Rachel H Clare
@en
Rachel H Clare
@es
Rachel H Clare
@nl
P106
P21
P31
P496
0000-0002-3945-0530